<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168242">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01990599</url>
  </required_header>
  <id_info>
    <org_study_id>1221/2012</org_study_id>
    <nct_id>NCT01990599</nct_id>
  </id_info>
  <brief_title>Airway Management for Trigeminal Thermal Coagulation</brief_title>
  <official_title>Airway Management in Patients Undergoing Thermal Ganglion Gasseri Coagulation, a New Method - Preliminary Results</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Airway management of patients undergoing thermal coagulation of the Gasserian ganglion is
      very delicate. This is because of the specific operation site and moreover patients should
      recover quickly from anesthesia to follow verbal intraoperative commands of the surgeon.
      Endotracheal intubation or laryngeal mask of course hinders the patient from speaking. An
      obvious alternative airway management, as performed in this preliminary study, is a
      nasopharyngeal placed tube.

      The purpose of the present study is to objectify the gas exchange in patients during this
      new ventilation technique.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Blood gas exchange</measure>
    <time_frame>Before and during the neurosurgical intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood gas analyses will be determined at three time points perioperatively. The first measurement, at base line, will be performed preoperatively, the second one after puncture of the Gasserian ganglion and the third during the thermal coagulation of the Gasserian ganglion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SpO2 oxygen saturation (pulse oximeter)</measure>
    <time_frame>Before and during the neurosurgical intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic parameters</measure>
    <time_frame>Before and during the neurosurgical intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Airway Management</condition>
  <arm_group>
    <arm_group_label>Nasopharyngeal Tube</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Every patient undergoing trigeminal thermal coagulation of the Gasserian ganglion will be ventilated by a nasopharyngeal placed ID 5mm tube during the whole neurosurgical intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nasopharyngeal Tube</intervention_name>
    <arm_group_label>Nasopharyngeal Tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients undergoing thermal coagulation of the Gasserian ganglion

        Exclusion Criteria:

          -  Body weight over 100 kg

          -  Recurrent nasal bleeding

          -  Patients suffering from reflux disease

          -  Additional risk of aspiration (e.g. hernia diaphragmalis)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 15, 2013</lastchanged_date>
  <firstreceived_date>November 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Wolfgang SCHRAMM</investigator_full_name>
    <investigator_title>Univ. Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>nasopharyngeal tube</keyword>
  <keyword>airway management</keyword>
  <keyword>thermal coagulation of the Gasserian ganglion</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
